TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Island Pharmaceuticals Ltd ( (AU:ILA) ).
Island Pharmaceuticals Ltd has been accepted into the Medical Countermeasures Coalition (MC2), a significant step in advancing its antiviral drug, Galidesivir, as a priority countermeasure. This membership is expected to bolster the company’s regulatory, clinical, and stockpiling efforts, enhancing its engagement with the US Government and positioning it alongside major biotechnology firms in the coalition.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd is an Australian company specializing in the development of antiviral drugs. The company focuses on creating critical countermeasures against high-priority threats, aiming for inclusion in government stockpiles.
Average Trading Volume: 752,237
Technical Sentiment Signal: Buy
Current Market Cap: A$132.4M
Find detailed analytics on ILA stock on TipRanks’ Stock Analysis page.